Roche received FDA clearance for a blood test for Alzheimer’s disease diagnosis.
Public source
Publisher name
Public post
𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫’𝐬 𝐭𝐨𝐨𝐤 𝐦𝐲 𝐠𝐫𝐚𝐧𝐝𝐟𝐚𝐭𝐡𝐞𝐫’𝐬 𝐦𝐞𝐦𝐨𝐫𝐢𝐞𝐬. 𝐈𝐭 𝐜𝐨𝐮𝐥𝐝𝐧’𝐭 𝐭𝐚𝐤𝐞 𝐡𝐢𝐬 𝐥𝐞𝐠𝐚𝐜𝐲. Years after his passing, his work cont…
Company
Roche
- Industry
- Biotechnology Research
- Location
- Switzerland 🇨🇭, CH
- Company size
- 10,001+ employees
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
See moreLatest activity
Latest activity from Roche
54 signals
Presence & Recognition
Roche celebrated its 30th anniversary in Slovenia.
Presence & Recognition
Roche participated in the RhK2026 conference in Leipzig on September 10, 2026, discussing the treatment of remission in SLE and lupus nephritis from both rheumatological and nephrological perspectives.
People
Roche is hiring a Medical Director for the Yale New Haven Hospital Multi-Specialty Long COVID Care Center to lead clinical care, clinic operations, and quality initiatives.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
ALZpath Inc.
ALZpath Inc. noted that ALZpath powered Roche Diagnostics USA's Elecsys pTau217 assay has received FDA clearance and expanded access through leading laboratories.
Legal & Regulatory
C2N Diagnostics
C2N Diagnostics received FDA clearance for the PrecivityAD2 blood test.
Legal & Regulatory
Labcorp
Labcorp received FDA clearance for its blood-based Alzheimer's disease test to help identify amyloid pathology.
Legal & Regulatory
Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation has received FDA clearance for four cleared blood tests, including Elecsys pTau217, which uses ALZpath Inc.'s proprietary pTau217 antibody.
Legal & Regulatory
Alzheimer's Therapeutic Research Institute (ATRI)